RU2153347C1 - Homeopathic medicinal agent for treatment of impotency - Google Patents
Homeopathic medicinal agent for treatment of impotency Download PDFInfo
- Publication number
- RU2153347C1 RU2153347C1 RU99111890/14A RU99111890A RU2153347C1 RU 2153347 C1 RU2153347 C1 RU 2153347C1 RU 99111890/14 A RU99111890/14 A RU 99111890/14A RU 99111890 A RU99111890 A RU 99111890A RU 2153347 C1 RU2153347 C1 RU 2153347C1
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- agent
- disappeared
- impotency
- increased
- Prior art date
Links
- 230000001632 homeopathic effect Effects 0.000 title claims description 13
- 239000008187 granular material Substances 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 8
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 7
- 235000018996 Nuphar luteum Nutrition 0.000 claims abstract description 6
- 244000020186 Nymphaea lutea Species 0.000 claims abstract description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 6
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 6
- 240000000143 Turnera diffusa Species 0.000 claims abstract description 6
- 235000001667 Vitex agnus castus Nutrition 0.000 claims abstract description 6
- 244000063464 Vitex agnus-castus Species 0.000 claims abstract description 6
- 235000009347 chasteberry Nutrition 0.000 claims abstract description 6
- 235000004952 turnera diffusa Nutrition 0.000 claims abstract description 6
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 claims abstract description 6
- 235000009206 Turnera diffusa Nutrition 0.000 claims abstract description 5
- 201000001881 impotence Diseases 0.000 claims description 5
- 239000012895 dilution Substances 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 abstract description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 210000000988 bone and bone Anatomy 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 210000000056 organ Anatomy 0.000 abstract description 3
- 210000002149 gonad Anatomy 0.000 abstract description 2
- 210000002700 urine Anatomy 0.000 abstract description 2
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 239000003061 homeopathic agent Substances 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- ZMOCWEDTNGYAMW-IOEZHPRESA-N (4ar,5as,8ar,13as,15as,15br)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2h-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinoline-14-one;phosphoric acid;dihydrate Chemical compound O.O.OP(O)(O)=O.O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 ZMOCWEDTNGYAMW-IOEZHPRESA-N 0.000 description 1
- XQMVBICWFFHDNN-UHFFFAOYSA-N 5-amino-4-chloro-2-phenylpyridazin-3-one;(2-ethoxy-3,3-dimethyl-2h-1-benzofuran-5-yl) methanesulfonate Chemical compound O=C1C(Cl)=C(N)C=NN1C1=CC=CC=C1.C1=C(OS(C)(=O)=O)C=C2C(C)(C)C(OCC)OC2=C1 XQMVBICWFFHDNN-UHFFFAOYSA-N 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 241000723368 Conium Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 244000007429 Dieffenbachia seguine Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000228186 Geum rivale Species 0.000 description 1
- 235000017354 Geum rivale Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000195947 Lycopodium Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000190079 Turnera Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- UFMZWBIQTDUYBN-UHFFFAOYSA-N cobalt dinitrate Chemical compound [Co+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O UFMZWBIQTDUYBN-UHFFFAOYSA-N 0.000 description 1
- 229910001981 cobalt nitrate Inorganic materials 0.000 description 1
- 229940000425 combination drug Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000009161 herbalism Methods 0.000 description 1
- CPSYWNLKRDURMG-UHFFFAOYSA-L hydron;manganese(2+);phosphate Chemical compound [Mn+2].OP([O-])([O-])=O CPSYWNLKRDURMG-UHFFFAOYSA-L 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LJCNRYVRMXRIQR-OLXYHTOASA-L potassium sodium L-tartrate Chemical compound [Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O LJCNRYVRMXRIQR-OLXYHTOASA-L 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 235000011006 sodium potassium tartrate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Изобретение относится к медицине, а именно к комбинированным гомеопатическим препаратам, стимулирующим функции мужских половых желез, и может применяться для лечения импотенции. Для лечения данной патологии из литературных и патентных данных известно использование аллопатических и гомеопатических средств природного происхождения. Известно средство для лечения импотенции, представляющее собой настой корневища гравилата речного Geum rivale (Энциклопедия травоцелительства, М., "Крон-пресс", 1998. С.552). The invention relates to medicine, namely to combined homeopathic medicines that stimulate the functions of the male sex glands, and can be used to treat impotence. For the treatment of this pathology from the literature and patent data, the use of allopathic and homeopathic remedies of natural origin is known. Known tool for the treatment of impotence, which is an infusion of the rhizome of the gravilate of the river Geum rivale (Encyclopedia of herbalism, M., "Cron-press", 1998. P.552).
Наиболее близким техническим решением к заявляемому является комбинированное гомеопатическое средство "Тестис композитум", содержащее Testis suis. Embryo suis, Glandula suprarenalis suis, Kalium picrinicum, Ginseng, Damiana suis, Caladium seguinum, Cor suis, Cortisonacetat, Agnus-castus, Selenium, Strychninum phosphoricum, Cantharis, Curar, Conium, Lycopodium, Phosphorus, Diencephalon suis, Magnesium phosphoricum, Ferrum phosphoricum, Manganum phosphoricum, Zincum metallicum. Vitamin С. Средство стимулирует функции мужских половых желез, обладает сосудорасширяющим, противовоспалительным, противосудорожным действием (Энциклопедия лекарств, РЛС России, 6 изд., М., 1999, с.814). The closest technical solution to the claimed is a combined homeopathic remedy "Testis compositum" containing Testis suis. Embryo suis, Glandula suprarenalis suis, Kalium picrinicum, Ginseng, Damiana suis, Caladium seguinum, Cor suis, Cortisonacetat, Agnus-castus, Selenium, Strychninum phosphoricum, Cantharis, Curar, Conium, Lycopodium, Phosphoricumumphrum, Dosphalis, Magnum, , Manganum phosphoricum, Zincum metallicum. Vitamin C. The agent stimulates the functions of the male gonads, has a vasodilating, anti-inflammatory, anticonvulsant effect (Encyclopedia of Medicines, Russian Radar, 6th ed., M., 1999, p.
Однако известные средства для лечения импотенции обладают определенными недостатками. Загрязнение воды и почвы солями тяжелых металлов и пестицидами, летучие токсические выбросы, присутствующие в воздухе, приводят к загрязнению лекарственного растительного сырья, использование которого вызывает аллергические и побочные эффекты со стороны организма больного. Жидкая лекарственная форма неудобна при дозировании средства и использовании его вне дома. Гиперчувствительность к отдельным компонентам состава также лимитирует использование некоторых комбинированных лекарственных средств. However, known agents for treating impotence have certain disadvantages. Pollution of water and soil with salts of heavy metals and pesticides, volatile toxic emissions present in the air lead to contamination of medicinal plant materials, the use of which causes allergic and side effects from the patient's body. Liquid dosage form is inconvenient when dosing and using it outside the home. Hypersensitivity to the individual components of the composition also limits the use of certain combination drugs.
Задачей настоящего изобретения является расширение арсенала отечественных гомеопатических средств, представляющих собой комбинированный препарат, направленный на расширение фармакологического спектра действия. The objective of the present invention is to expand the arsenal of domestic homeopathic remedies, which are a combined preparation aimed at expanding the pharmacological spectrum of action.
Предлагаемое гомеопатическое средство лечит состояние истощения как следствие перенапряжения, нервное возбуждение, депрессию, бессонницу, стимулирует функции половых органов, предотвращает истощение и преждевременное старение, лечит воспаления мочеполовых органов, препятствует снижению содержания кальция в костной ткани. The proposed homeopathic remedy treats a state of exhaustion as a result of overexertion, nervous agitation, depression, insomnia, stimulates the functions of the genitals, prevents exhaustion and premature aging, treats inflammation of the urogenital organs, and prevents a decrease in the calcium content in bone tissue.
Поставленная задача достигается тем, что гомеопатическое лекарственное средство для лечения импотенции, помимо Vitex agnus-castus, дополнительно содержит Yohimbinum, Panax pseudoginseng, Acidum phosphoricum, Turnera diffilsa, Nuphar lutea, взятые в равных соотношениях, при определенном разведении компонентов:
Vitex agnus-castus - C3
Yohimbinum - C3
Panax pseudoginseng - C3
Acidum phosphoricum - C3
Turnera diffusa - C3
Nuphar lutea - C3
Предлагаемое средство может быть выполнено в виде сахарных гранул.The task is achieved in that the homeopathic medicine for treating impotence, in addition to Vitex agnus-castus, additionally contains Yohimbinum, Panax pseudoginseng, Acidum phosphoricum, Turnera diffilsa, Nuphar lutea, taken in equal proportions, with a certain dilution of the components:
Vitex agnus-castus - C3
Yohimbinum - C3
Panax pseudoginseng - C3
Acidum phosphoricum - C3
Turnera diffusa - C3
Nuphar lutea - C3
The proposed tool can be made in the form of sugar granules.
Все входящие в заявленный состав компоненты известны в гомеопатии и разрешены в медицинской практике (Гомеопатическая фармакопея Германии, 1985). All components included in the claimed composition are known in homeopathy and are permitted in medical practice (Homeopathic Pharmacopoeia of Germany, 1985).
Изобретение иллюстрируется следующим примером. The invention is illustrated by the following example.
Пример:
Состав. На 100 г гранул:
Vitex agnus-castus C3 - 0,17 г
Yohimbinum C3 - 0,17 г
Panax pseudoginseng C3 - 0,17 г
Acidum phosphoricum C3 - 0,17 г
Turnera diffusa C3 - 0,17 г
Nuphar lutea C3 - 0,17 г
Вспомогательные вещества (
Сахарная крупка по ГОСТ 7060-79 - до 100 г
Заявляемое средство получают следующим образом, 100 г ненасыщенных гранул гомеопатических увлажняют 1 г спирта этилового 45 % в закрытом сосуде, затем добавляют поровну потенцированные растворы гомеопатических компонентов, входящих в состав комплексного препарата, и динамизируют в течение 10 минут.Example:
Structure. Per 100 g of granules:
Vitex agnus-castus C3 - 0.17 g
Yohimbinum C3 - 0.17 g
Panax pseudoginseng C3 - 0.17 g
Acidum phosphoricum C3 - 0.17 g
Turnera diffusa C3 - 0.17 g
Nuphar lutea C3 - 0.17 g
Excipients (
Sugar grains according to GOST 7060-79 - up to 100 g
The inventive tool is prepared as follows, 100 g of unsaturated homeopathic granules moisturize 1 g of ethyl alcohol 45% in a closed vessel, then evenly potentiated solutions of homeopathic components that are part of the complex preparation are added and dynamized for 10 minutes.
Характеристика конечного продукта
Внешний вид. Однородные гранулы правильной шаровидной формы белого с серым или кремовым оттенком цвета, без запаха.End product characterization
Appearance. Homogeneous granules of regular spherical shape in white with a gray or cream shade, odorless.
Подлинность. Authenticity.
1. 5 гранул помещают в колбу вместительностью 50 мл, прибавляют 1 мл 1 % раствора кислоты хлористоводородной и нагревают на кипящей бане до полного растворения гранул в течение 5 минут. Затем прибавляют 2 мл реактива Фелинга и нагревают на кипящей водяной бане в течение 5 минут. Выпадает осадок кирпично-красного цвета (сахара). 1. 5 granules are placed in a 50 ml flask, 1 ml of a 1% hydrochloric acid solution is added and heated in a boiling bath until the granules are completely dissolved within 5 minutes. Then add 2 ml of Feling's reagent and heat in a boiling water bath for 5 minutes. The precipitate is brick red (sugar).
2. 2 гранулы растворяют в 0,5 мл воды, прибавляют 0,1 мл раствора натрия гидроксида, 0,1 мл раствора кобальта нитрата; появляется сине-фиолетовое окрашивание (сахара). 2. 2 granules are dissolved in 0.5 ml of water, 0.1 ml of sodium hydroxide solution, 0.1 ml of cobalt nitrate solution are added; appears blue-violet staining (sugar).
Примечание. Приготовление реактива Фелинга по ГФ 11 изд., вып.2, с. 125. При отсутствии сегнетовой соли реактив Фелинга готовят следующим образом: около 3,5 г перекристаллизованного меди сульфата (ГОСТ 4165-78) растворяют в 50 мл воды, подкисленной 2 каплями кислоты серной разведенной. Note. Preparation of the Feling reagent according to the Global Fund 11th ed., Issue 2, p. 125. In the absence of Rochelle salt, the Feling reagent is prepared as follows: about 3.5 g of recrystallized copper sulfate (GOST 4165-78) is dissolved in 50 ml of water, acidified with 2 drops of diluted sulfuric acid.
Клинические испытания проведены на базе Московского гомеопатического центра. Clinical trials were conducted on the basis of the Moscow Homeopathic Center.
Противопоказания и побочные эффекты не выявлены. No contraindications and side effects have been identified.
Взаимодействие с другими препаратами: не выявлено. Interaction with other drugs: not detected.
Дозировка и способ применения: по 8 гранул 5 раз в день под язык до полного рассасывания за 15 минут до еды. Dosage and method of application: 8 granules 5 times a day under the tongue until complete resorption 15 minutes before meals.
Курс лечения 3 месяца. По рекомендации врача в зависимости от тяжести заболевания и состояния организма курс лечения повторяют через 1 месяц. The course of treatment is 3 months. On the recommendation of a doctor, depending on the severity of the disease and the condition of the body, the treatment is repeated after 1 month.
Лечение предложенным средством приводит к улучшению общего состояния: постепенно исчезают депрессии, нормализуется сон, проходит нервное возбуждение, уменьшаются или исчезают воспалительные явления в мочеполовых органах, повышается содержание кальция в костной ткани, уровень 17-кетостероидов в моче несколько повышается и достигает значений физиологической нормы, происходит восстановление функции мужских половых желез, что приводит к восстановлению потенции. Treatment with the proposed remedy leads to an improvement in the general condition: depression gradually disappears, sleep normalizes, nervous agitation goes away, inflammation in the genitourinary organs decreases or disappears, the calcium content in the bone tissue rises, the level of 17-ketosteroids in the urine increases slightly and reaches the physiological norm, there is a restoration of the function of the male sex glands, which leads to the restoration of potency.
Claims (1)
Vitex agnus-castus - C3
Yohimbinum - C3
Panax pseudoginseng - C3
Acidum phosphoricim - C3
Turnera diffusa - C3
Nuphar lutea - C3
2. Гомеопатическое лекарственное средство по п.1, отличающееся тем, что оно выполнено в виде гранул.1. Homeopathic medicine for the treatment of impotence, containing Vitex agnus-castus, characterized in that it further comprises Yohimbinum, Panax pseudoginseng, Acidum phosphoricim, Turnera diffusa, Nuphar lutea, taken in equal proportions, with the following dilution of the components:
Vitex agnus-castus - C3
Yohimbinum - C3
Panax pseudoginseng - C3
Acidum phosphoricim - C3
Turnera diffusa - C3
Nuphar lutea - C3
2. Homeopathic medicine according to claim 1, characterized in that it is made in the form of granules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99111890/14A RU2153347C1 (en) | 1999-06-04 | 1999-06-04 | Homeopathic medicinal agent for treatment of impotency |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU99111890/14A RU2153347C1 (en) | 1999-06-04 | 1999-06-04 | Homeopathic medicinal agent for treatment of impotency |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2153347C1 true RU2153347C1 (en) | 2000-07-27 |
Family
ID=20220820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU99111890/14A RU2153347C1 (en) | 1999-06-04 | 1999-06-04 | Homeopathic medicinal agent for treatment of impotency |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2153347C1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002094270A3 (en) * | 2001-05-18 | 2003-04-03 | Chemokine Therapeutics Corp | Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases |
| WO2003094943A1 (en) * | 2002-05-10 | 2003-11-20 | Indena S.P.A. | Formulations useful in the treatment of male and female impotence |
| RU2313358C2 (en) * | 2002-05-10 | 2007-12-27 | Индена С.П.А. | Preparative formulations useful in treatment of male and female impotency |
-
1999
- 1999-06-04 RU RU99111890/14A patent/RU2153347C1/en not_active IP Right Cessation
Non-Patent Citations (1)
| Title |
|---|
| 1. Энциклопедия травоцелительства. - М.: Крон-пресс, 1998, с.552. 2. Энциклопедия лекарств России, 1999, 6 изд., с.814. * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002094270A3 (en) * | 2001-05-18 | 2003-04-03 | Chemokine Therapeutics Corp | Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases |
| WO2003094943A1 (en) * | 2002-05-10 | 2003-11-20 | Indena S.P.A. | Formulations useful in the treatment of male and female impotence |
| US7128932B2 (en) | 2002-05-10 | 2006-10-31 | Indena S.P.A. | Formulations useful in the treatment of male and female impotence |
| RU2313357C2 (en) * | 2002-05-10 | 2007-12-27 | Индена С.П.А. | Medicinal formulation useful in treatment of male and female impotency |
| RU2313358C2 (en) * | 2002-05-10 | 2007-12-27 | Индена С.П.А. | Preparative formulations useful in treatment of male and female impotency |
| RU2440127C2 (en) * | 2002-05-10 | 2012-01-20 | Индена С.П.А. | Dosage forms effective for male and female sexual frustration |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2153347C1 (en) | Homeopathic medicinal agent for treatment of impotency | |
| RU2143917C1 (en) | Homeopathic drug for treatment of patient with influenza and acute respiratory viral infections | |
| CN101590169B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
| RU2143275C1 (en) | Homeopathic drug "valeriana-plus multigran" for treatment of patients with insomnia and increased nervous excitability | |
| RU2153348C1 (en) | Homeopathic medicinal agent for treatment of polyarthritis, arthrosis, rheumatism | |
| RU2143271C1 (en) | Homeopathic drug "peoniya-plus multigran" for treatment of patients with varicosity and hemorrhoid | |
| RU2143915C1 (en) | Homeopathic drug for treatment of patient with menstrual cycle disorder | |
| RU2145867C1 (en) | Homeopathic drug for treatment of patients with liver diseases | |
| RU2145868C1 (en) | Homeopathic drug for treatment of patients with urolithiasis and renal lithiasis | |
| RU2152795C1 (en) | Homeopathic drug for maxillary sinusitis treatment | |
| RU2152796C1 (en) | Homeopathic drug for treatment of climacteric menopause | |
| RU2143916C1 (en) | Homeopathic drug for treatment of patient with cystic fibrosis mastopathy | |
| RU2145866C1 (en) | Homeopathic drug for lipid metabolism normalization | |
| RU2137492C1 (en) | Renal species | |
| RU2146940C1 (en) | Drug for treatment of erection disorder | |
| RU2143273C1 (en) | Homeopathic drug "evkalipt-plus multigran" for treatment of patients with cough | |
| RU2308964C2 (en) | Homeopathic suppository "hemoprost-t" (variants) | |
| RU2151610C1 (en) | Homeopathic drug for treatment of alcoholic dependency | |
| RU2143274C1 (en) | Homeopathic drug "tabakum-plus multigran" for treatment of patients with tobacco dependence | |
| RU2145865C1 (en) | Homeopathic drug for treatment of patients with eczema and diathesis | |
| CN1240430C (en) | Medicine for preventing and treating chronic exhaustion syndrome and preparing mthod thereof | |
| FR2616067A1 (en) | Product consisting of metals of different atomic masses and densities which acts against viruses and microbes | |
| RU2143276C1 (en) | Homeopathic drug "aurum-plus multigran" for treatment of patients with atherosclerosis | |
| CN103070977A (en) | Traditional Chinese medicine composition for treating bone diseases and preparation of traditional Chinese medicine composition | |
| RU2241471C1 (en) | Suppository for treatment of chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20040605 |
|
| NF4A | Reinstatement of patent | ||
| PD4A | Correction of name of patent owner | ||
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20180605 |